उत्पाद विवरण
Bharglob 16.5% Injection is a specialized immunosuppressive medication designed to address immunoglobulin deficiencies, whether they are congenital or acquired. This injection is particularly beneficial for patients suffering from primary immunodeficiency, which is present from birth, as well as secondary immunodeficiency that develops later in life. In addition to supporting those with low immunoglobulin levels, Bharglob is effectively utilized in managing various inflammatory conditions, including primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy. By modulating the immune response, this treatment aids in reducing inflammation and restoring balance in the immune system. It is important for patients to be aware of potential side effects, including increased susceptibility to infections due to its immunosuppressive nature. Prior to administration, a healthcare professional should evaluate the patient's medical history and any concurrent medications to ensure safety. With its targeted approach, Bharglob 16.5% Injection plays a crucial role in improving the quality of life for individuals facing these challenging health conditions.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese